|
Tuesday, November 18th, 2008
|
Contact Us at (800)768.2671
|
|
|
|
|
|
Education:
  1985-1989 College of Eastern UT Price, UT
  1989-1994 Bachelors Degree in Music Bringham Young University Provo, UT
  1994-1998 Doctor of Podiatric Medicine California College of Podiatric medicine San Francisco, CA
  1998-2001 Residency VAMC - Surgical Residency Program Salt Lake City, UT
Work Experience:
  2001 - Present Foot and Ankle Institute in association with Dr. Keith R. Reber, Dr. Lary J. Smith, Dr. Carl C. Van Gils and Dr. Kent Burton
Professional Associations:
  American Podiatric Medical Association
  Dixie Regional medical Center - Staff Physician
  St. George Surgical Center - Staff physician
  South Main Surgical Center - Staff Physician
  American College of Foot and Ankle Surgeons
Research Experience:
Foot & Ankle Institute
  Sub Investigator - Multicenter, double-blind, randomized, placebo-control, parallel-group study to evaluate the safety and efficacy of XXXX in patients with neuropathic pain due to diabetic neuropathy.
  Sub Investigator - Clinical Protocol for a Double-Blind, Placebo and Active-Controlled Comparison of the Analgesic Activity of XXXX 40 Mg, Oxycodone 10 Mg/Acetaminophen 1000 Mg (Tylox) and Placebo in Post-Bunionectomy Surgical Patients.
  Sub Investigator - A Double-Blind, Randomized, Controlled Study of the Analgesic Efficacy and Tolerance of Hydrocodone 5 mg/APAP 500 mg, Hydrocodone 10 mg/APAP 1000 mg and Placebo in Patients with Pain Following Bunion Surgery.
  Sub Investigator - A Multi-Center, Double-Blind, Randomized, Parallel Group, Two-Period Study To Evaluate The Efficacy And Safety Of Oral Doses Of An Extended-Release Combination Of XXXX and XXXX, Extended-Release Hydrocodone 15 mg Tablets, Extended-Release Acetaminophen 1000 mg Tablets, And Placebo In The Treatment Of Moderate To Severe Pain In Subjects Undergoing Orthopedic Surgery.
  Sub Investigator - Linezolid IV or PO Compared to Unasyn(IV or Augmentin(Po for the Treatment of Patients with Diabetic Foot Infections-A Randomized, Open Label Phase IV Clinical Trial.
  Sub Investigator - A Multicenter, Double Blind, Double Dummy, Placebo-Controlled Parallel Group Study to Compare the Efficacy, Safety and Tolerability of New Oral Formulation XXXX in Patients with Onychomycosis of the Toenails.
  Sub Investigator - A Multicenter, Randomized, Double Blind, Parallel-Group, Single Dose, Placebo-Controlled, Active Comparator Study of the Efficacy and Safety of XXXX in Subjects Following Bunionectomy Surgery.
  Sub Investigator - A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Multiple-Dose Pilot Study Assessing The Analgesic Efficacy And Safety Of Two- Dose Levels Of XXXX Compared To Intravenous Morphine And Placebo In Patients Following Orthopedic Surgery (Bunionectomy).
|
|
|
|